BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang M, Zheng H, Xu K, Yuan Q, Aihaiti Y, Cai Y, Xu P. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA. Front Immunol 2022;13:919231. [DOI: 10.3389/fimmu.2022.919231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu QT, Wang ZW, Cai MY, Wei JF, Ding Q. A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer. Front Pharmacol 2022;13:1115608. [PMID: 36699089 DOI: 10.3389/fphar.2022.1115608] [Reference Citation Analysis]
2 Wang W, Chen Z, Hua Y. Bioinformatics Prediction and Experimental Validation Identify a Novel Cuproptosis-Related Gene Signature in Human Synovial Inflammation during Osteoarthritis Progression. Biomolecules 2023;13. [PMID: 36671512 DOI: 10.3390/biom13010127] [Reference Citation Analysis]
3 Li D, Shi Z, Liu X, Jin S, Chen P, Zhang Y, Chen G, Fan X, Yang J, Lin H. Identification and development of a novel risk model based on cuproptosis-associated RNA methylation regulators for predicting prognosis and characterizing immune status in hepatocellular carcinoma. Hepatol Int 2023. [PMID: 36598701 DOI: 10.1007/s12072-022-10460-2] [Reference Citation Analysis]
4 Chu B, Zheng H, Zheng X, Feng X, Hong Z. Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims. Front Cell Dev Biol 2022;10:989882. [PMID: 36589745 DOI: 10.3389/fcell.2022.989882] [Reference Citation Analysis]
5 Chen J, Guan Y, Li C, Du H, Liang C. Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer. Discov Oncol 2022;13:133. [PMID: 36454396 DOI: 10.1007/s12672-022-00596-w] [Reference Citation Analysis]
6 Lai X, Liu N, Liu L, Huang X, Xiong T, Li C, Hu W. Prognostic Prediction and Immunotherapy Analysis of Basement Membranes-Related Genes in Osteosarcoma Based on Bioinformatics.. [DOI: 10.21203/rs.3.rs-2306174/v1] [Reference Citation Analysis]
7 Bai Y, Zhang Q, Liu F, Quan J. A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1027449] [Reference Citation Analysis]
8 Wang L, Yao B, Yang J, Tian Z, He J. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma. BMC Cancer 2022;22:1131. [DOI: 10.1186/s12885-022-10175-5] [Reference Citation Analysis]
9 Wang Z, Yao J, Dong T, Niu X, Wang F. Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma. Journal of Immunology Research 2022;2022:1-40. [DOI: 10.1155/2022/2756611] [Reference Citation Analysis]